Pharmacokinetics and safety of a single dose of the novel LAMA/LABA fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler, formulated using co-suspension delivery technology, in Japanese healthy subjects

Graphic titled ‘Pharmacokinetics and safety of a single dose of a LAMA/LABA fixed‑dose glycopyrronium/formoterol MDI’ with a ‘View Publication’ button and the Pharmaron logo

Capabilities

Knowledge Center
Laboratory Chemistry
Connect with a Scientific Expert

Authors: Reisner, C; Miller, J; DePetrillo, P; Maes, A; Siddiqui, S; Martin, U.J.

Pulm Pharmacol Ther. 2018 Dec:53:33-38

DOI: 10.1016/j.pupt.2018.09.005

Access the publication at:https://pubmed.ncbi.nlm.nih.gov/30218695/